LIVE

VHI

Valhi, Inc.

VHI

NYSE·Basic Materials·Chemicals·Mkt cap $408.1M

$14.40

-0.14%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$11.44 - $20.00

P/E

-5.65

Fwd P/E

4.15

Beta

0.96

Div Yield

2.22%

Avg Vol

13.8K

Shares Out

28.3M

Mkt Cap

$408.1M

Price action

Price chart

Down 21.1% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Established KRONOS brand recognition in global titanium dioxide markets with multi-decade heritage
  • Diversified revenue streams across chemicals, industrial components, and real estate reduce cyclical exposure
  • Strategic parent company backing from Contran Corporation providing financial stability and operational synergies
  • Integrated supply chain and manufacturing capabilities across multiple geographies and product lines

Bear Case

1 risk

  • Average volatility.

Growth

Turning profitable

Rising global demand for titanium dioxide in emerging markets and specialty applications

Value

Deep value opportunity - significant discount to Commodity Chemicals peers

Momentum

Stable

+2.8% over 3m

Quality

Thin

Mixed fundamentals

Dividend

Solid

2.22% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 6, 2026

Q2 26 RECAP

MAY 7, 2026

Reported EPS of $0.07 vs $0.77 consensus (-90.9% surprise). Revenue of $560.1M vs $564.2M expected (-0.7%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-90.9%

Next: May 6, 2026

Revenue trend · last 8Q

+6%

+2%

-3%

-6%

+3%

+4%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$559.7M

$533.6M

$480.9M

$538.6M

$540.4M

$503.5M

$494.5M

$560.1M

Margins · last 8Q

Gross

Operating

Profit

0.4%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

vs Industry

How VHI stacks vs Chemicals

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.